Clinical Trial Update: Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quality of life in women with dysmenorrhea treated with Arcoxia (etoricoxib) has completed. The study assessed patient-reported outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Arcoxia (Etoricoxib)

Snippet

Sponsor: Organon and Co | Conditions: Pain | Phase 4 | Status: COMPLETED